Donna L. Senger

4.7k total citations
55 papers, 3.0k citations indexed

About

Donna L. Senger is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Donna L. Senger has authored 55 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Genetics and 11 papers in Oncology. Recurrent topics in Donna L. Senger's work include Virus-based gene therapy research (18 papers), Glioma Diagnosis and Treatment (9 papers) and RNA Interference and Gene Delivery (7 papers). Donna L. Senger is often cited by papers focused on Virus-based gene therapy research (18 papers), Glioma Diagnosis and Treatment (9 papers) and RNA Interference and Gene Delivery (7 papers). Donna L. Senger collaborates with scholars based in Canada, United States and Australia. Donna L. Senger's co-authors include Peter Forsyth, John C. Bell, Kelley A. Parato, Robert B. Campenot, Stephen M. Robbins, Tommy Alain, Mark G. Hamilton, Xueqing Lun, J. Gregory Cairncross and Wenqing Yang and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and Nature reviews. Cancer.

In The Last Decade

Donna L. Senger

51 papers receiving 2.9k citations

Peers

Donna L. Senger
Magnus Essand Sweden
Derek A. Persons United States
Gaetano Romano United States
Eugenio Montini Italy
Angelo Lombardo Italy
Steven P. Smeekens United States
Hans Herweijer United States
Kurt M. Kroeger United States
G J Rosman United States
Sushrusha Nayak United States
Magnus Essand Sweden
Donna L. Senger
Citations per year, relative to Donna L. Senger Donna L. Senger (= 1×) peers Magnus Essand

Countries citing papers authored by Donna L. Senger

Since Specialization
Citations

This map shows the geographic impact of Donna L. Senger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna L. Senger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna L. Senger more than expected).

Fields of papers citing papers by Donna L. Senger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna L. Senger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna L. Senger. The network helps show where Donna L. Senger may publish in the future.

Co-authorship network of co-authors of Donna L. Senger

This figure shows the co-authorship network connecting the top 25 collaborators of Donna L. Senger. A scholar is included among the top collaborators of Donna L. Senger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna L. Senger. Donna L. Senger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fletcher, Jamie I., Loretta M. S. Lau, M. Emmy M. Dolman, et al.. (2025). Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy. Cancer Research Communications. 5(7). 1215–1227.
2.
Lopes-Rodrigues, Vanessa, Xueqing Lun, Jianbo Zhang, et al.. (2025). Impaired migration and lung invasion of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75NTR. EMBO Molecular Medicine. 17(10). 2661–2690. 2 indexed citations
3.
4.
Lau, Arthur, Jennifer J. Rahn, Hyunjae Chung, et al.. (2022). Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury. Science Advances. 8(5). eabm0142–eabm0142. 62 indexed citations
5.
Sarkar, Susobhan, Reza Mirzaei, Franz J. Zemp, et al.. (2017). Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells. Cancer Research. 77(12). 3231–3243. 56 indexed citations
6.
Alshehri, Mana, Stephen M. Robbins, & Donna L. Senger. (2017). The Role of Neurotrophin Signaling in Gliomagenesis. Vitamins and hormones. 104. 367–404. 11 indexed citations
7.
Lun, Xueqing, J. Connor Wells, Natalie Grinshtein, et al.. (2016). Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma. Clinical Cancer Research. 22(15). 3860–3875. 169 indexed citations
8.
Robbins, Stephen M., et al.. (2016). N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells. Molecular Therapy — Oncolytics. 3. 16005–16005. 3 indexed citations
9.
Sarkar, Susobhan, Franz J. Zemp, Donna L. Senger, Stephen M. Robbins, & V. Wee Yong. (2015). ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor–initiating cells. Neuro-Oncology. 17(8). 1095–1105. 52 indexed citations
10.
Nguyen, Stephanie A., Owen D.M. Stechishin, H. Artee Luchman, et al.. (2014). Novel MSH6 Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of MGMT Promoter Methylation. Clinical Cancer Research. 20(18). 4894–4903. 50 indexed citations
11.
Alain, Tommy, Franz J. Zemp, Hongyuan Zhou, et al.. (2010). Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin. Cancer Research. 70(2). 598–608. 89 indexed citations
12.
Lun, Xueqing, Jennifer A. Chan, Hongyuan Zhou, et al.. (2010). Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma. Molecular Therapy. 18(11). 1927–1936. 77 indexed citations
13.
Lun, Xueqing, Hongyuan Zhou, Limei Wang, et al.. (2008). Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors. Clinical Cancer Research. 14(4). 1218–1227. 46 indexed citations
14.
Wang, Limei, Jennifer J. Rahn, Xueqing Lun, et al.. (2008). Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor. PLoS Biology. 6(11). e289–e289. 55 indexed citations
15.
Zhou, Hongyuan, Tommy Alain, Beichen Sun, et al.. (2007). Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin. Cancer Research. 67(18). 8818–8827. 88 indexed citations
16.
Lun, Xueqing, Jennifer J. Rahn, Abdelhamid Liacini, et al.. (2007). The p75 Neurotrophin Receptor Is a Central Regulator of Glioma Invasion. PLoS Biology. 5(8). e212–e212. 135 indexed citations
17.
Alain, Tommy, et al.. (2007). Proteolytic Disassembly Is a Critical Determinant for Reovirus Oncolysis. Molecular Therapy. 15(8). 1512–1521. 70 indexed citations
18.
Yang, Wenqing, Donna L. Senger, Huong Muzik, et al.. (2004). Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer. Gene Therapy. 11(21). 1579–1589. 37 indexed citations
19.
Senger, Donna L., J. Gregory Cairncross, & Peter Forsyth. (2003). Long-Term Survivors of Glioblastoma. The Cancer Journal. 9(3). 214–221. 45 indexed citations
20.
Toma, Jean G., David T. Rogers, Donna L. Senger, Robert B. Campenot, & Freda D. Miller. (1997). Spatial Regulation of Neuronal Gene Expression in Response to Nerve Growth Factor. Developmental Biology. 184(1). 1–9. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magnus Essand Breakdown of academic impact, for papers by Derek A. Persons Breakdown of academic impact, for papers by Gaetano Romano Breakdown of academic impact, for papers by Eugenio Montini Breakdown of academic impact, for papers by Angelo Lombardo Breakdown of academic impact, for papers by Steven P. Smeekens Breakdown of academic impact, for papers by Hans Herweijer Breakdown of academic impact, for papers by Kurt M. Kroeger Breakdown of academic impact, for papers by G J Rosman Breakdown of academic impact, for papers by Sushrusha Nayak
Rankless by CCL
2026